Transparency interrupted: the curtailment of the European Medicines Agency's Policy on access to documents

JAMA Intern Med. 2013 Nov 25;173(21):2009-11. doi: 10.1001/jamainternmed.2013.9989.
No abstract available

MeSH terms

  • Access to Information*
  • Clinical Trials as Topic*
  • Commerce*
  • Drug Industry* / standards
  • European Union*
  • Government Agencies
  • Humans
  • United States